Rogers SL - Search Results

1

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study.

Rogers SL, Friedhoff LT. Rogers SL, et al. Eur Neuropsychopharmacol. 1998 Feb;8(1):67-75. doi: 10.1016/s0924-977x(97)00079-5. Eur Neuropsychopharmacol. 1998. PMID: 9452942 Clinical Trial.

2

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. Rogers SL, et al. Neurology. 1998 Jan;50(1):136-45. doi: 10.1212/wnl.50.1.136. Neurology. 1998. PMID: 9443470 Clinical Trial.

3

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients.

Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD; "312" Study Group. Mohs RC, et al. Among authors: rogers sl. Neurology. 2001 Aug 14;57(3):481-8. doi: 10.1212/wnl.57.3.481. Neurology. 2001. PMID: 11502917 Clinical Trial.

4

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study.

Rogers SL, Doody RS, Pratt RD, Ieni JR. Rogers SL, et al. Eur Neuropsychopharmacol. 2000 May;10(3):195-203. doi: 10.1016/s0924-977x(00)00067-5. Eur Neuropsychopharmacol. 2000. PMID: 10793322 Clinical Trial.

5

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT. Burns A, et al. Among authors: rogers sl. Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):237-44. doi: 10.1159/000017126. Dement Geriatr Cogn Disord. 1999. PMID: 10325453 Clinical Trial.

6

Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.

Rogers SL. Rogers SL. Dement Geriatr Cogn Disord. 1998;9 Suppl 3:29-42. doi: 10.1159/000051201. Dement Geriatr Cogn Disord. 1998. PMID: 9853200 Review.

7

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration.

Tiseo PJ, Rogers SL, Friedhoff LT. Tiseo PJ, et al. Among authors: rogers sl. Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):13-8. doi: 10.1046/j.1365-2125.1998.0460s1013.x. Br J Clin Pharmacol. 1998. PMID: 9839760 Free PMC article. Clinical Trial.

8

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses.

Rogers SL, Cooper NM, Sukovaty R, Pederson JE, Lee JN, Friedhoff LT. Rogers SL, et al. Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):7-12. doi: 10.1046/j.1365-2125.1998.0460s1007.x. Br J Clin Pharmacol. 1998. PMID: 9839759 Free PMC article. Clinical Trial.

9

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.

Rogers SL, Friedhoff LT. Rogers SL, et al. Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):1-6. doi: 10.1046/j.1365-2125.1998.0460s1001.x. Br J Clin Pharmacol. 1998. PMID: 9839758 Free PMC article. Clinical Trial.

10

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Rogers SL, et al. Arch Intern Med. 1998 May 11;158(9):1021-31. doi: 10.1001/archinte.158.9.1021. Arch Intern Med. 1998. PMID: 9588436 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results